What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Achatin Gene Ontology: Mechanisms, Methods, and Missteps

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Introduction to Achatin and Its Gene Ontology

What is Achatin?

Achatin is a neuropeptide first isolated from the ganglia of the African giant land snail Achatina fulica in the late 1980s. It is a tetrapeptide with the primary sequence Gly-D-Phe-Ala-Asp, notable for containing a D-form amino acid residue—a rare post-translational modification in animal peptides. The D-phenylalanine at position 2 is not a sequencing artifact; it arises from an isomerase that converts an L-Phe to D-Phe during peptide processing. This single stereochemical inversion profoundly alters the peptide's receptor selectivity and metabolic stability, as D-amino acid-containing peptides resist degradation by standard aminopeptidases.

Achatin was initially characterized as an excitatory neurotransmitter candidate in molluscan neurons. Subsequent work identified a second peptide, achatina cardio-excitatory peptide (ACEP), but "achatin" in the molecular biology literature refers specifically to the tetrapeptide and its precursor gene. The precursor is a small prohormone (~90 amino acids) that undergoes proteolytic cleavage at dibasic sites to yield the mature peptide. In the gene ontology (GO) framework, achatin is annotated as a gene product with defined molecular functions, participation in biological processes, and localization to specific cellular components.

Gene Ontology (GO) Basics

The Gene Ontology is a structured, controlled vocabulary that describes gene product attributes across three orthogonal domains: molecular function (MF), biological process (BP), and cellular component (CC). Each term is a node in a directed acyclic graph, connected by "is a," "part of," and "regulates" relationships. Annotations are statements that associate a gene product with a GO term, supported by an evidence code and a reference.

For achatin, the GO annotation framework captures three distinct aspects. The molecular function domain describes what the peptide does biochemically—binding to its receptor, modulating ion channel activity. The biological process domain captures the higher-level physiological outcomes—neurotransmission, regulation of feeding behavior. The cellular component domain specifies where the peptide resides—synaptic vesicles, extracellular space. Critically, GO terms are species-neutral; a term like "neuropeptide signaling pathway" applies whether the organism is a snail or a mouse. This neutrality enables cross-species comparisons and orthology-based annotation transfer, but it also creates pitfalls when context-dependent functions are ignored. For a deeper treatment of how GO terms are used in enrichment workflows, see Gene Ontology Pathway Enrichment.

Molecular Function of Achatin

Receptor Interactions

The primary molecular function of achatin is receptor binding and activation. Achatin acts through a G protein-coupled receptor (GPCR) that belongs to the rhodopsin family. In A. fulica, the achatin receptor (AchR) was cloned and shown to couple to Gq, leading to phospholipase C activation, inositol trisphosphate (IP₃) production, and intracellular calcium mobilization. The receptor is activated by achatin at nanomolar concentrations (EC₅₀ ≈ 10–50 nM), and the D-Phe residue is essential for this activity; the all-L stereoisomer is at least 100-fold less potent.

The GO molecular function term most commonly applied to achatin is "neuropeptide hormone activity" (GO:0005184), which is defined as the action of a peptide hormone on a receptor to elicit a cellular response. More specific annotations include "G protein-coupled receptor binding" (GO:0001664) and, where evidence supports direct channel interaction, "ion channel modulator activity" (GO:0008200). It is important to note that GO distinguishes between the ligand (achatin) and the receptor (AchR). The ligand is annotated with "receptor ligand activity," while the receptor is annotated with "signaling receptor activity" and "G protein-coupled receptor activity" (GO:0004930). Confusing these two annotation targets is a common error in GO analysis.

Ion Channel Modulation

Beyond GPCR-mediated signaling, achatin has been reported to directly modulate ion channels in some neuronal preparations. In isolated A. fulica neurons, achatin application enhances a voltage-gated calcium current and suppresses a delayed rectifier potassium current. These effects are observed within milliseconds of peptide application, suggesting a membrane-delimited pathway, possibly via G protein βγ subunits directly interacting with channel proteins—a mechanism well established for other neuropeptides like substance P and bradykinin.

The GO term "voltage-gated calcium channel activity" (GO:0005245) is not applied to achatin itself, as the peptide is not a channel. Instead, the appropriate annotation is "calcium channel regulator activity" (GO:0016247) or "ion channel modulator activity." This distinction matters in enrichment analyses: if you run a Gene Ontology Analysis Online tool and see "ion channel activity" enriched in a list of achatin-interacting proteins, the annotation may be on the channel subunits, not on achatin. Always check the annotated gene product before interpreting enrichment results.

Biological Processes Involving Achatin

Neurotransmission

Achatin's best-characterized biological process is excitatory neurotransmission. In the buccal ganglia of A. fulica, achatin is released from presynaptic terminals and depolarizes postsynaptic neurons, increasing the frequency of action potentials. This effect is mediated by the Gq-coupled receptor described above, which produces a slow excitatory postsynaptic potential (EPSP) lasting hundreds of milliseconds—a time course consistent with IP₃-mediated calcium release and subsequent activation of calcium-dependent cation channels.

The GO biological process term "chemical synaptic transmission" (GO:0007268) is the parent term for this activity. More specific annotations include "neuropeptide signaling pathway" (GO:0007218) and "regulation of membrane potential" (GO:0042391). In the context of synaptic transmission, achatin functions as a neuromodulator rather than a fast neurotransmitter: it does not gate ligand-gated ion channels directly but instead alters the excitability of the postsynaptic neuron through second messenger cascades. This distinction is captured in GO by the difference between "neurotransmitter receptor activity" and "neuropeptide receptor activity."

Neuroendocrine Regulation

Achatin also participates in neuroendocrine regulation, particularly in the control of feeding behavior and cardiovascular function. In A. fulica, achatin-immunoreactive neurons project to the neurohemal area of the cerebral ganglia, where peptides are released into the hemolymph (the molluscan equivalent of blood). Hemolymph achatin levels rise after feeding, and exogenous achatin injection increases heart rate and hemolymph pressure, consistent with a role in coordinating the physiological response to food intake.

The relevant GO biological process terms include "regulation of feeding behavior" (GO:0060259), "regulation of heart contraction" (GO:0008016), and the broader "neuroendocrine process" (GO:0046160). These annotations are typically supported by evidence from physiological experiments—peptide application, immunoneutralization, or receptor antagonists—and are assigned with the evidence code IMP (inferred from mutant phenotype) or IDA (inferred from direct assay), depending on the experimental design.

Cellular Localization and Expression Patterns

Subcellular Localization

Achatin is synthesized as a preprohormone in the neuronal cell body, trafficked through the endoplasmic reticulum and Golgi apparatus, and packaged into dense-core vesicles (DCVs) for transport to synaptic terminals. Within the terminal, achatin is stored in DCVs distinct from the small clear vesicles that contain classical neurotransmitters like acetylcholine. Upon depolarization, DCVs fuse with the presynaptic membrane, releasing achatin into the synaptic cleft.

The GO cellular component terms applied to achatin include "dense core granule" (GO:0031045), "synaptic vesicle" (GO:0008021), and "extracellular space" (GO:0005615). The distinction between "synaptic vesicle" and "dense core granule" is functionally significant: DCVs release their contents at a distance from the active zone, and their exocytosis requires higher-frequency stimulation than small clear vesicles. If you are examining achatin localization by immunoelectron microscopy, you should annotate to "dense core granule" if the gold particles label large (80–120 nm) vesicles, and to "synaptic vesicle" only if labeling is associated with small (40–60 nm) vesicles. Misannotation here will propagate errors into downstream Gene Ontology Biological analyses.

Tissue Distribution

Achatin expression is restricted to the nervous system, with the highest levels in the buccal ganglia, cerebral ganglia, and pedal ganglia of gastropods. In situ hybridization and immunohistochemistry reveal achatin-positive neurons in defined clusters, including the B1–B3 neurons of the buccal ganglia, which are identifiable by their large soma size (100–200 µm in diameter) and stereotyped positions.

In mammals, no true achatin ortholog has been identified. The closest sequence relatives are the RFamide-related peptides, but these share only the C-terminal amide motif and differ substantially in their precursor structure and receptor selectivity. This absence of a mammalian ortholog has important implications for GO annotation transfer (discussed in Section 5) and for the design of translational studies. Researchers who wish to study achatin in a mammalian context must either use heterologous expression systems (e.g., transfecting the snail receptor into HEK293 cells) or work with the native molluscan system.

Evolutionary Conservation and Orthology

Ortholog Identification

Orthologs are genes in different species that descend from a single ancestral gene. For achatin, ortholog identification is complicated by the rapid evolution of neuropeptide genes. The achatin precursor is short (~90 amino acids), and the mature peptide is only four residues. Sequence alignment algorithms like BLASTP often fail to detect homology beyond closely related gastropod species because the signal is diluted by the variable regions of the precursor.

A more reliable approach is synteny-based orthology: comparing the genomic neighborhood of the achatin locus across species. In A. fulica, Biomphalaria glabrata, and Lymnaea stagnalis, the achatin gene is flanked by conserved genes encoding a potassium channel tetramerization domain-containing protein and a solute carrier family 6 member. This conserved synteny provides strong evidence of orthology even when sequence identity in the peptide region is low. For GO annotation transfer, the Gene Ontology Analysis Tool you use should incorporate orthology-based propagation with the evidence code IEA (inferred from electronic annotation) or ISS (inferred from sequence or structural similarity), and you should treat these annotations with appropriate caution.

Comparative Genomics

Comparative genomic studies have identified achatin-like peptides in other molluscan classes, including bivalves and cephalopods, but not in arthropods, nematodes, or deuterostomes. This distribution suggests that achatin arose early in the molluscan lineage, possibly in a common ancestor of gastropods and bivalves, and was lost or diverged beyond recognition in other protostome lineages.

The functional implications of this restricted distribution are significant. If you are studying a biological process in a non-molluscan model organism (e.g., Drosophila or C. elegans), achatin will not appear in your gene list, and any GO enrichment analysis will not detect achatin-related terms. Conversely, if you are working with a molluscan genome and identify an achatin-like sequence, you should verify that the D-amino acid isomerase responsible for the D-Phe modification is also present. The isomerase has been identified as a separate gene product, and its absence would mean the peptide is produced in the all-L form, which has dramatically different receptor activity.

Methods for Studying Achatin Function

Electrophysiology

The gold-standard method for studying achatin function is intracellular electrophysiology in identified molluscan neurons. The large soma of buccal ganglion neurons (100–200 µm) permits stable impalement with sharp microelectrodes (20–40 MΩ resistance when filled with 3 M KCl). Typical protocols involve:

Dissect the buccal ganglia from an adult A. fulica (shell length 5–8 cm) and pin them to a Sylgard-lined recording chamber.
Superfuse with physiological saline containing (in mM): NaCl 85, KCl 4, CaCl₂ 8, MgCl₂ 7, HEPES 10, pH 7.4, at room temperature (22–24°C).
Impale a identified B1 or B2 neuron with a sharp microelectrode; accept recordings with resting membrane potential more negative than −45 mV and action potential overshoot greater than +10 mV.
Apply achatin by pressure ejection (10–100 µM in the pipette, 10–50 ms pulses) or by bath perfusion (0.1–10 µM).
Record membrane potential in current-clamp mode or ionic currents in voltage-clamp mode using a two-electrode voltage clamp amplifier.

Achatin typically produces a depolarization of 5–20 mV and an increase in input resistance, consistent with closure of a resting potassium conductance. In voltage-clamp, the peptide evokes an inward current at holding potentials near −60 mV, with a reversal potential around −20 mV, suggesting activation of a nonselective cation conductance.

Gene Editing Approaches

CRISPR-Cas9-mediated knockout of the achatin precursor gene has been achieved in Lymnaea stagnalis, a freshwater snail with a sequenced genome and established transgenesis protocols. The approach uses single-guide RNAs (sgRNAs) targeting the first exon of the achatin precursor, delivered by microinjection into one-cell embryos. Typical injection mixes contain 100 ng/µL Cas9 protein, 50 ng/µL sgRNA, and 0.05% phenol red in 10 mM HEPES buffer (pH 7.4). Surviving F0 animals are screened by PCR amplification of the target locus followed by T7 endonuclease I digestion to detect indels.

Knockout animals show reduced feeding behavior and altered heart rate variability, confirming the physiological roles predicted from pharmacological experiments. However, because the D-amino acid isomerase is a separate gene, CRISPR knockout of the precursor does not eliminate the possibility of compensatory upregulation of other neuropeptides. For rigorous loss-of-function studies, you should combine precursor knockout with receptor knockout or with pharmacological antagonism using a selective achatin receptor antagonist.

For transcriptomic-level analysis of achatin knockout effects, you would perform RNA-seq and then use Differential Gene Expression Analysis Deseq2 to identify differentially expressed genes, followed by GO enrichment to identify affected pathways. This workflow is standard but requires careful attention to the annotation quality of the reference genome, as discussed in Section 8.

Bioinformatics and GO Annotation Resources

Major Databases

Several databases provide GO annotations for achatin and related neuropeptides:

UniProtKB: The primary repository for protein sequence and functional annotation. The achatin precursor from A. fulica has the accession P31413 (ACHAT_ACHFU). The GO annotations are listed under the "Ontologies" section of the entry, with evidence codes and source references.
Ensembl Metazoa: Provides genome-scale annotations, including GO terms, for non-model organisms. The achatin gene can be retrieved by BLAST search against the B. glabrata or L. stagnalis genomes.
AmiGO: The official GO browser and search engine. A search for "achatin" returns all gene products annotated to achatin-related terms, with links to the supporting evidence.
QuickGO: A fast, programmatically accessible GO annotation browser maintained by the European Bioinformatics Institute (EBI).

For enrichment analysis, you will typically upload a list of differentially expressed genes to a tool like the Gene Ontology Online Tool or the Gene Ontology Analysis Tool. These tools accept gene identifiers (UniProt accessions, Ensembl gene IDs, or official gene symbols) and return statistically enriched GO terms using hypergeometric or Fisher's exact tests, with multiple-testing correction (Benjamini-Hochberg false discovery rate is standard).

Evidence Codes and Curation

GO evidence codes are essential for interpreting annotation quality. The codes most relevant to achatin are:

Evidence Code	Meaning	Example for Achatin
IDA	Inferred from Direct Assay	Achatin binding to AchR measured by radioligand binding
IMP	Inferred from Mutant Phenotype	CRISPR knockout of achatin precursor reduces feeding
IEP	Inferred from Expression Pattern	In situ hybridization shows achatin mRNA in buccal ganglia
IEA	Inferred from Electronic Annotation	GO terms propagated from a closely related species by sequence similarity
ISS	Inferred from Sequence or Structural Similarity	Achatin-like peptide identified by BLAST in B. glabrata
TAS	Traceable Author Statement	A review article states that achatin modulates calcium channels

IEA annotations are the least reliable and should be treated as hypotheses rather than established facts. When you run an enrichment analysis, you can filter by evidence code to exclude IEA annotations, which is often advisable for hypothesis-generating analyses. The Gene Ontology Pathway Enrichment resource provides guidance on filtering strategies.

Common Pitfalls and Misinterpretations

Context-Dependent Roles

Achatin's function is highly context-dependent. In the buccal ganglion, it is excitatory; in the pedal ganglion, it has been reported to inhibit spontaneous activity in some neurons. This context dependence is not captured by GO annotations, which are binary (a gene product either has a function or does not). The GO term "regulation of membrane potential" (GO:0042391) can be annotated with either "positive" or "negative" regulation, but the annotation does not specify the neuron type, the developmental stage, or the physiological state.

A common misstep is to overgeneralize from one experimental system. If achatin depolarizes B1 neurons in A. fulica, it does not follow that achatin depolarizes all molluscan neurons. Before drawing conclusions, verify the annotation's supporting evidence: which species, which cell type, which experimental conditions? The GO annotation itself is not the finding; it is a summary of a finding.

Annotation Errors

Several specific annotation errors recur in achatin research:

Confusing ligand and receptor: Achatin is annotated with "neuropeptide hormone activity"; the receptor is annotated with "G protein-coupled receptor activity." If you see "achatin" in a list of genes annotated to "G protein-coupled receptor activity," the annotation is wrong or the gene identifier is ambiguous.

Over-annotation of "extracellular space": Achatin is found in the extracellular space after release, but it is also intracellular (in DCVs) before release. The GO cellular component annotation should reflect the experimentally determined localization, not the presumed site of action. If your immunostaining shows punctate intracellular labeling, the correct term is "dense core granule," not "extracellular space."

Ignoring the D-amino acid modification: The D-Phe residue is essential for achatin's receptor activity. If you are annotating a putative achatin ortholog from a species where the isomerase is absent, you should not transfer the "neuropeptide hormone activity" annotation without experimental verification. The peptide may be produced but biologically inactive.

Using GO enrichment on poorly annotated genomes: If you are working with a non-model mollusc whose genome annotation is sparse, GO enrichment will be biased toward well-annotated genes. This bias can produce false-positive enrichment of housekeeping functions and false-negative results for neuropeptide signaling. Consider using Differential Gene Expression Dge Analysis methods that account for annotation bias, or restrict your analysis to high-confidence annotations.

Misinterpreting "regulation of" terms: GO distinguishes between "regulation of X" and "X." Achatin is annotated to "regulation of feeding behavior," not "feeding behavior." The distinction matters: achatin does not itself constitute feeding behavior; it modulates the neural circuits that produce feeding. Enrichment of "regulation of feeding behavior" in your gene list is not equivalent to enrichment of "feeding behavior."

Summary and Practical Recommendations

Achatin is a molluscan neuropeptide with well-defined molecular functions (GPCR binding, ion channel modulation), biological processes (neurotransmission, neuroendocrine regulation), and cellular components (dense-core granules, extracellular space). Its GO annotations are valuable for comparative and evolutionary studies, but they must be interpreted with attention to evidence codes, context dependence, and the distinction between ligand and receptor.

For students and postdocs working with achatin, the following recommendations are practical:

Always check the evidence code before trusting a GO annotation. Prefer IDA, IMP, and TAS over IEA.
Verify the species and cell type associated with each annotation. GO terms are species-neutral, but the underlying experiments are not.
When running enrichment analyses, filter out IEA annotations if your goal is hypothesis generation, and include them only if you are willing to validate the results experimentally.
Use synteny-based orthology detection for neuropeptide genes, not BLAST alone.
If you are working in a non-molluscan system, do not expect achatin to appear in your gene lists; its absence is biologically meaningful, not an annotation gap.
For transcriptomic studies, use Differential Gene Expression Analysis in R with a robust statistical framework (e.g., DESeq2 with shrinkage estimators) before proceeding to GO enrichment.

Frequently Asked Questions

What is the gene ontology for achatin?

The gene ontology for achatin includes molecular function terms such as "neuropeptide hormone activity" (GO:0005184) and "G protein-coupled receptor binding" (GO:0001664); biological process terms such as "neuropeptide signaling pathway" (GO:0007218) and "regulation of feeding behavior" (GO:0060259); and cellular component terms such as "dense core granule" (GO:0031045) and "extracellular space" (GO:0005615). The specific set of annotations depends on the species and the experimental evidence available.

How is achatin annotated in GO databases?

Achatin is annotated in UniProtKB (accession P31413 for the A. fulica precursor) and in Ensembl Metazoa for other molluscan species. Annotations are assigned by curators based on published experimental evidence, with each annotation linked to an evidence code (IDA, IMP, IEP, etc.) and a PubMed reference. Electronic annotations (IEA) are also present and should be treated with caution.

What is the molecular function of achatin?

Achatin's primary molecular function is activation of a Gq-coupled GPCR, leading to phospholipase C activation and intracellular calcium mobilization. It also modulates voltage-gated calcium and potassium channels, likely through membrane-delimited G protein signaling. The D-Phe residue at position 2 is essential for receptor binding and activation.

What biological processes is achatin involved in?

Achatin is involved in excitatory neurotransmission in the buccal ganglia, neuroendocrine regulation of feeding and cardiovascular function, and modulation of neuronal excitability. It acts as a slow neuromodulator rather than a fast neurotransmitter, with effects lasting hundreds of milliseconds to seconds.

Where is achatin expressed in the body?

Achatin is expressed exclusively in the nervous system of gastropod molluscs, with highest levels in the buccal, cerebral, and pedal ganglia. Within neurons, it is localized to dense-core vesicles and released into the synaptic cleft and hemolymph.

How do researchers study achatin function?

Researchers use intracellular electrophysiology in identified molluscan neurons, calcium imaging with fluorescent indicators (e.g., Fura-2 or GCaMP), CRISPR-Cas9 knockout of the precursor or receptor genes, and behavioral assays for feeding and heart rate. Peptide application and receptor antagonists are used for pharmacological characterization.

Is achatin conserved across species?

Achatin is conserved across gastropod and bivalve molluscs but has no identifiable ortholog in arthropods, nematodes, or deuterostomes. Orthology is best established by conserved synteny rather than sequence similarity alone, given the small size of the mature peptide.

What are common mistakes in achatin GO analysis?

Common mistakes include confusing the ligand (achatin) with its receptor in GO annotations, overgeneralizing context-dependent functions across cell types, trusting IEA annotations without experimental validation, and misinterpreting "regulation of" terms as the process itself. Annotation bias in poorly assembled genomes is another frequent issue.

Key Takeaways

Achatin is a D-amino acid-containing tetrapeptide neuropeptide from molluscs, acting through a Gq-coupled GPCR to modulate neuronal excitability.
GO annotations for achatin span molecular function (receptor binding, channel modulation), biological process (neurotransmission, feeding regulation), and cellular component (dense-core granules, extracellular space).
Evidence codes are critical: IDA and IMP are experimentally robust; IEA annotations are computational predictions and should be validated.
Achatin's function is context-dependent; annotations do not capture cell-type or state-specific effects.
Orthology detection for achatin requires synteny-based methods; BLAST alone is insufficient for short neuropeptide precursors.
CRISPR-Cas9 knockout in Lymnaea stagnalis is a viable approach for loss-of-function studies, but compensatory mechanisms must be considered.
When performing GO enrichment, filter annotations by evidence code and be aware of genome annotation bias in non-model organisms.